Cited by 405Alzheimer's disease research and treatmentsHistone Deacetylase Inhibitors ResearchCholinesterase and Neurodegenerative Diseases

Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression

Open access
Govindarajan, Nambirajan, Agis-Balboa, Roberto Carlos, Walter, Jonas, Sananbenesi, Farahnaz, Fischer, André·2011·Journal of Alzheimer's Disease

Abstract

Dysregulation of histone acetylation has been implicated in the onset of age-associated memory impairment and the pathogenesis of neurodegenerative diseases. Elevation of histone acetylation via administration of histone deacetylase (HDAC) inhibitors is currently being pursued as a novel therapeutic avenue to treat memory impairment linked to Alzheimer's disease (AD). Here we show that severe amyloid pathology correlates with a pronounced dysregulation of histone acetylation in the forebrain of APPPS1-21 mice. Importantly, prolonged treatment with the pan-HDAC inhibitor sodium butyrate improved associative memory in APPPS1-21 mice even when administered at a very advanced stage of pathology. The recovery of memory function correlated with elevated hippocampal histone acetylation and increased expression of genes implicated in associative learning. These data advance our understanding of the potential applicability of HDAC inhibitors for the treatment of AD and suggest that HDAC inhibitors may have beneficial effects even when administered long after the onset of disease-associated symptoms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-2011-110080

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Key neuropathological processes underlying AD might also be modulated by SCFAs.

    “Accumulating evidence has demonstrated that key neuropathological processes underlying AD might also be modulated by SCFAs (25, 34, 158, 159).”
  • Through HDAC inhibition, butyrate administration recovered memory function and increased expression of genes implicated in associative learning in the APP/PS1 mouse model of AD.

    “Finally, through HDAC inhibition, butyrate administration recovered memory function and increased expression of genes implicated in associative learning in the APP/PS1 mouse model of AD (158).”

    From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [158]

    The indexed copy provides a repository listing for the paper (Journal of Alzheimer’s Disease 26(1), pp. 187–197), but the passages returned for associative-learning genes and HDAC inhibition are from its abstract, not its full text. Searches for those terms returned no results or discussion passage from the paper, so the attributed findings cannot be verified from the available eligible text. (LLM, conf=0.72)

    Experimental — accuracy not yet measured
  • Benzamide compound 1 has a significantly different binding mode, in which the thiophene group is inserted into the foot pocket.

    “The benzamide compound 1 has a significantly different binding mode, in which the thiophene group is inserted into the 'foot pocket' (Fig. 3 B ) (20-23, 32, 33).”

    From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [21]

    The available indexed text under the Journal of Alzheimer's Disease 26(1), pp. 187–197 listing discusses sodium butyrate, histone acetylation, and memory in an Alzheimer’s mouse model. Searches for “benzamide compound 1,” “thiophene,” and “foot pocket” found no passage addressing the claimed binding mode. The available copy therefore does not verify this attribution. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Govindarajan, N., Agis-Balboa, R. C., Walter, J., Sananbenesi, F., & Fischer, A.
Affiliations
  • Universitätsmedizin Göttingen (DE)
  • Laboratory of Aging and Cognitive Diseases, European Neuroscience Institute Goettingen, University Medicine Goettingen, Goettingen, Germany
Corresponding author
Fischer, André
Venue
Journal of Alzheimer's Disease
Published
2011-08-26
Volume
26
Issue
1
Pages
187-197
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W1883566698
Cited by
405
References
3
Citations by year
2026: 26 · 2025: 31 · 2024: 45 · 2023: 45 · 2022: 41 · 2021: 38 · 2020: 27 · 2019: 17 · 2018: 22 · 2017: 20 · 2016: 16 · 2015: 12 · 2014: 21 · 2013: 24 · 2012: 16
FWCI
13.97
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
  • GRO (submittedVersion)
Funders
  • Deutsche Forschungsgemeinschaft
  • Hans und Ilse Breuer-Stiftung
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
Keywords
sodium butyrate, Alzheimer's disease
MeSH terms
Acetylation, Alzheimer Disease, Analysis of Variance, Animals, Avoidance Learning, Brain, Butyrates, Disease Models, Animal, Electroshock, Exploratory Behavior, Gene Expression Regulation, Histones, Locomotion, Memory Disorders, Mice, Transgenic, Nerve Tissue Proteins, Amyloid beta-Protein Precursor, Microscopy, Confocal, Freezing Reaction, Cataleptic, Mice, Histone Acetyltransferases, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review